Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EFINACONAZOLE Cause Product packaging quantity issue? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product packaging quantity issue have been filed in association with EFINACONAZOLE (JUBLIA). This represents 1.3% of all adverse event reports for EFINACONAZOLE.

16
Reports of Product packaging quantity issue with EFINACONAZOLE
1.3%
of all EFINACONAZOLE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Product packaging quantity issue From EFINACONAZOLE?

Of the 16 reports, 3 (18.8%) required hospitalization.

Is Product packaging quantity issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EFINACONAZOLE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does EFINACONAZOLE Cause?

Drug ineffective (344) Pain (149) Headache (138) Oedema peripheral (136) Drug hypersensitivity (135) Fatigue (135) Asthenia (133) Musculoskeletal stiffness (133) Anaemia (132) Pyrexia (131)

What Other Drugs Cause Product packaging quantity issue?

LEUPROLIDE (523) ALBUTEROL (431) BUDESONIDE\FORMOTEROL (301) FENTANYL (286) BUPRENORPHINE (225) CYCLOSPORINE (206) ESTRADIOL (201) BIMATOPROST (177) RIVAROXABAN (174) EXENATIDE (154)

Which EFINACONAZOLE Alternatives Have Lower Product packaging quantity issue Risk?

EFINACONAZOLE vs EFLORNITHINE EFINACONAZOLE vs EFMOROCTOCOG ALFA EFINACONAZOLE vs EFTRENONACOG ALFA EFINACONAZOLE vs EGG PHOSPHOLIPIDS\GLYCERIN\MEDIUM-CHAIN TRIGLYCERIDES\SOYBEAN OIL EFINACONAZOLE vs EGG PHOSPHOLIPIDS\GLYCERIN\SOYBEAN OIL

Related Pages

EFINACONAZOLE Full Profile All Product packaging quantity issue Reports All Drugs Causing Product packaging quantity issue EFINACONAZOLE Demographics